Advertisement
Screener

Zyla Life Sciences Retained Earnings

Zyla Life Sciences Retained Earnings

Zyla Life Sciences had Retained Earnings of -$64.88 million as of 2020-03-31, per its 10-Q filed 2020-05-14.

Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent

us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-05-14

  • 2020-03-31: Retained Earnings (Accumulated Deficit) -$64.88M.
  • 2019-12-31: Retained Earnings (Accumulated Deficit) -$46.64M.
  • 2019-09-30: Retained Earnings (Accumulated Deficit) -$40.42M.
  • 2019-06-30: Retained Earnings (Accumulated Deficit) -$30.13M.
Period endRetained Earnings (Accumulated Deficit)Retained Earnings (Accumulated Deficit) as first filed
2020-03-31-$64.88M
10-Q · filed 2020-05-14
2019-12-31-$46.64M
10-Q · filed 2020-05-14
2019-09-30-$40.42M
10-Q · filed 2019-11-14
2019-06-30-$30.13M
10-Q · filed 2019-08-13
2019-03-31-$10.48M
10-Q · filed 2019-05-17
2019-01-31-$395.80M
10-Q · filed 2020-05-14
2018-12-31-$388.85M
10-K · filed 2020-03-26
2018-09-30-$368.94M
10-Q · filed 2018-11-19
2018-06-30-$317.71M
10-Q · filed 2018-08-09
2018-03-31-$305.75M
10-Q · filed 2018-05-10
2018-01-02-$293.40M
10-Q · filed 2018-05-10
2018-01-01-$293.40M
10-K · filed 2019-03-29
-$293.40M
10-Q · filed 2018-08-09
2017-12-31-$295.30M
10-K · filed 2019-03-29
2017-09-30-$296.74M
10-Q · filed 2017-11-08
2017-06-30-$277.79M
10-Q · filed 2017-08-09
2017-03-31-$251.31M
10-Q · filed 2017-05-10
2016-12-31-$225.18M
10-K · filed 2018-03-16
2016-09-30-$203.81M
10-Q · filed 2016-11-08
2016-06-30-$176.87M
10-Q · filed 2016-08-05
2016-03-31-$153.09M
10-Q · filed 2016-05-10
2015-12-31-$134.55M
10-K · filed 2017-03-13
2015-09-30-$127.78M
10-Q · filed 2015-11-06
2015-06-30-$110.42M
10-Q · filed 2015-08-07
2015-03-31-$93.33M
10-Q · filed 2015-05-08
2014-12-31-$76.61M
10-K · filed 2016-03-11
2014-09-30-$68.15M
10-Q · filed 2014-11-14
2014-06-30-$57.97M
10-Q · filed 2014-08-14
2014-03-31-$46.31M
10-Q · filed 2014-06-11
2013-12-31-$33.40M
10-K · filed 2015-03-16